Bcel stock forecast.

Atreca Inc [BCEL] stock is trading at $0.22, up 8.95%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. ... An investor can expect a potential return of 1377.27% based on the average BCEL price forecast. Analyzing the BCEL fundamentals. In the same period, the company ...$0.220 +0.0047 (+2.19%) At Close: Nov 30, 2023 Real-time prices appear during market hours U.S. markets are closed | Score: -1.37 Strong Sell Hold Strong Buy …Stock Price Forecast. The 17 analysts offering 12-month price forecasts for BCE Inc have a median target of 41.19, with a high estimate of 45.64 and a low estimate of 39.16. The median estimate ...Price target. 3.25 0.00 0.00%. The 4 analysts offering 1 year price forecasts for BCEL have a max estimate of — and a min estimate of —.

The current Atreca [ BCEL] share price is $0.21. The Score for BCEL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. BCEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels. Stock Price Forecast. The 18 analysts offering 12-month price forecasts for Keurig Dr Pepper Inc have a median target of 37.00, with a high estimate of 42.00 and a low estimate of 27.00. The ...

Find real-time BCE - BCE Inc stock quotes, company profile, news and forecasts from CNN Business.At the time of writing, Atreca Inc [BCEL] stock is trading at $0.21, saw in change for the day. In order to assess the stock's recent performance, you can check whether its short-term value is rising or falling. The BCEL shares have gain 4.79% over the last week, with a monthly amount drifted -4.55%, and

Atreca Inc (NASDAQ:BCEL) 0.2302. Delayed Data. As of Nov 30. +0.0047 / +2.19%. Today’s Change. 0.19. Today ||| 52-Week Range. 2.05.BCEL Stock 12 Months Forecast $2.00 (790.87% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Atreca in the last 3 months. The average price target …Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company’s product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-002 and VRDN ...Nasdaq +78.81(+0.55%) Russell 2000 1,862.64 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Atreca, Inc. (BCEL) NasdaqGS - NasdaqGS Real Time Price. Currency in USD...

Price target. 1.93D CAD +1.58 +451.02%. The 7 analysts offering 1 year price forecasts for ENTHUSIAST GAMING HOLDINGS INC have a max estimate of 2.50 and a min estimate of 1.50.

4/13 ratings generated profit. 31%. Average Return. -37.24%. reiterated a buy rating 10 months ago. Copying Do Kim 's trades and holding each position for 1 Year would result in 30.77% of your transactions generating a profit, with an average return of -37.24% per trade. 2 Years. dummy dummy.

A list of analyst ratings for Atreca (BCEL) stock. See upgrades, downgrades, price targets and more from top Wall Street stock analysts. ... Forecast; Analyst Ratings; BCEL's stock price has decreased by -82.11% in the past year and price targets may not have had time to catch up.Nov 23, 2023 · Science. Atreca Inc (NASDAQ:BCEL)’s traded shares stood at 0.33 million during the last session, with the company’s beta value hitting 1.24. At the close of trading, the stock’s price was $0.21. The BCEL share’s 52-week high remains $2.05, putting it -876.19% down since that peak but still an impressive 9.52% since price per share fell ... The Cymabay Therapeutics Inc stock price gained 1.86% on the last trading day (Thursday, 30th Nov 2023), rising from $18.78 to $19.13. During the last trading day the stock fluctuated 4.76% from a day low at $18.89 to a day high of $19.79. The price has risen in 6 of the last 10 days and is up by 6.28% over the past 2 weeks.Dec 1, 2023 · Atreca, Inc. - Hold. Zacks' proprietary data indicates that Atreca, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the BCEL shares relative to the market in ... Find real-time BCE - BCE Inc stock quotes, company profile, news and forecasts from CNN Business. Analyst Forecast. According to 5 analysts, the average rating for BCEL stock is "Hold." The 12-month stock price forecast is $3.38, which is an increase of 1,479.44% from the latest price.

3 Wall Street research analysts have issued 1-year price targets for Tecnoglass' shares. Their TGLS share price targets range from $43.00 to $54.00. On average, they anticipate the company's stock price to reach $48.20 in the next year. This suggests a possible upside of 30.2% from the stock's current price.Stock Price Forecast. The 18 analysts offering 12-month price forecasts for Nu Holdings Ltd have a median target of 9.75, with a high estimate of 16.00 and a low estimate of 6.00. The median ...3 Wall Street research analysts have issued 1-year price targets for Tecnoglass' shares. Their TGLS share price targets range from $43.00 to $54.00. On average, they anticipate the company's stock price to reach $48.20 in the next year. This suggests a possible upside of 30.2% from the stock's current price.VKTX Stock 12 Months Forecast. $34.00. (187.40% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Viking Therapeutics in the last 3 months. The average price target is $34.00 with a high forecast of $40.00 and a low forecast of $28.00. The average price target represents a 187.40% change from the last price of $11.83.Earnings announcement* for BCEL: Our vendor, Zacks Investment Research, hasn't provided us with the upcoming earnings report date. BCEL has a "high" Earnings Quality Ranking (EQR) for the 5th ...The latest Atreca stock prices, stock quotes, news, and BCEL history to help you invest and trade smarter. ... The 11 analysts offering price forecasts for Atreca have a median target of 11.77 ...

According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.The current average BCEL price target, as estimated by these analysts, is $4.00. The predictions for the future BCEL stock price range from a low of $4.00 to a high of $4.00, highlighting the variability of market expectations for BCEL.

BCEL stock forecast Our latest prediction for Atreca Inc's stock price was made on the July 20, 2020 when the stock price was at 15.10$.. In the short term (2weeks), BCEL's stock price should outperform the market by 2.41%.During that period the price should oscillate between -10.29% and +13.88%.. In the medium term (3months), BCEL's stock …The 6 analysts offering 12-month price forecasts for Tecnoglass Inc have a median target of 50.00, with a high estimate of 56.00 and a low estimate of 45.00. The median estimate represents a +40. ...Atreca Inc [BCEL] stock is trading at $0.22, up 8.95%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. ... An investor can expect a potential return of 1377.27% based on the average BCEL price forecast. Analyzing the BCEL fundamentals. In the same period, the company ...11.30% of Atreca stock is owned by insiders. Which Atreca insiders have been selling company stock? The following insiders have sold BCEL shares in the last 24 months: Bros. Advisors Lp Baker ($109,895.60), John A Orwin ($37,216.24), Phillips Courtney ($15,321.16), and Tito Serafini ($199,122.53).Atreca, Inc. (BCEL) stock forecast and price target. Find the latest Atreca, Inc. BCEL analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.Atreca Inc. Cl A analyst ratings, historical stock prices, earnings estimates & actuals. BCEL updated stock price target summary. BCEL BCEL Atreca Inc - Ordinary Shares - Class A 2,464 Watch Alerts $0.223 $0.0092 (4.30%) Today $0.23 0.0035 (1.57%) After Hours About Feed News Sentiment Earnings …Nov 30, 2023 · 5 equities research analysts have issued twelve-month target prices for Atreca's stock. Their BCEL share price targets range from $4.00 to $25.00. On average, they expect the company's stock price to reach $10.75 in the next twelve months. This suggests a possible upside of 4,474.5% from the stock's current price. Weather forecasting plays a crucial role in our daily lives, helping us plan our activities and make informed decisions. But have you ever wondered how meteorologists are able to accurately predict the weather? One of the key components in ...

Forecst.com predicts future values using technical analysis of a large number of analytical parameters. BCEL stock returns are also predicted based on historical data. According to our research, BCEL stock is a bad long-term investment. BCEL share price has been in a bear cycle for the past year. Atreca, Inc. stock trend is negative .

Find the latest Patterson-UTI Energy, Inc. (PTEN) stock quote, history, news and other vital information to help you with your stock trading and investing.

The average Terran Orbital stock price prediction forecasts a potential upside of 731.23% from the current LLAP share price of $0.79. What is LLAP's forecast return on equity (ROE) for 2023-2026? (NYSE: LLAP) forecast ROE is N/A, which is considered weak.LNG Stock 12 Months Forecast. Based on 11 Wall Street analysts offering 12 month price targets for Cheniere Energy in the last 3 months. The average price target is $203.36 with a high forecast of $229.00 and a low forecast of $185.00. The average price target represents a 13.00% change from the last price of $179.96.The BCEL shares have gain 4.62% over the last week, with a monthly amount glided 4.62%, and seem to be holding up well As of right now, Atreca Inc [BCEL] is trading at $0.22, up 2.19%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value.Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Viking Therapeutics Inc have a median target of 34.00, with a high estimate of 40.00 and a low estimate of 28.00. The ...Dec 2, 2023 · The consensus price target of analysts on Wall Street is $2.00, which implies an increase of 89.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2.00 and $2.00 respectively. As a result, BCEL is trading at a discount of -809.09% off the target high and -809.09% off the low. Atreca Stock Forecast and Price Target. According to six esteemed experts, the average price target for Atreca to reach this year is $17.00, with a potential upside of approximately 1,600%. This prediction is based on a high estimate of $35.00 and a low estimate of $11.00.Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform.May 6, 2023 · Atreca Stock Forecast and Price Target. According to six esteemed experts, the average price target for Atreca to reach this year is $17.00, with a potential upside of approximately 1,600%. This prediction is based on a high estimate of $35.00 and a low estimate of $11.00. Predicting the weather has long been one of life’s great mysteries — at least for regular folks. Over the years, you’ve probably encountered a few older adults — maybe even your own grandparents — who made some weather predictions based on ...

According to analyst projections, BCEL’s forecast low is $1.00 with $9.00 as the target high. To hit the forecast high, the stock’s price needs a -4185.71% plunge from its current level, while the stock would need to soar -376.19% for it to hit the projected low. Atreca Inc (BCEL) estimates and forecastsAtreca Inc Cl A (BCEL) Company Description. Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism ... How much is Atreca stock worth today? ( NASDAQ: BCEL) Atreca currently has 39,295,661 outstanding shares. With Atreca stock trading at $0.27 per share, the total value of Atreca stock (market capitalization) is $10.41M. Atreca stock was originally listed at a price of $18.05 in Jun 20, 2019.12 analysts have issued twelve-month price objectives for CymaBay Therapeutics' stock. Their CBAY share price targets range from $12.00 to $34.00. On average, they anticipate the company's stock price to reach $22.27 in the next year. This suggests a possible upside of 24.4% from the stock's current price. View analysts price targets for CBAY ...Instagram:https://instagram. dental insurance plans for veteransiwd etfdividends payment datespros and cons of anthem blue cross Fiscal Q3 2023 ended 9/30/23. Get the latest Atreca Inc (BCEL) real-time quote, historical performance, charts, and other financial information to help you make more informed …Nov 30, 2023 · The Atreca Inc. stock price gained 5.36% on the last trading day (Friday, 17th Nov 2023), rising from $0.209 to $0.220. During the last trading day the stock fluctuated 9.33% from a day low at $0.210 to a day high of $0.230. The price has been going up and down for this period, and there has been a -16.59% loss for the last 2 weeks. where to buy arm ipowarner bro discovery stock Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust... first solar inc stock Wall Street Stock Market & Finance report, prediction for the future: You'll find the Cheniere Energy share forecasts, stock quote and buy / sell signals below. According to present data Cheniere Energy's LNG shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).This reflects a positive earnings surprise of 12.50%. Look out for BCEL's next earnings release expected on November 09, 2023. For the next earning release, we expect the company to report ... Fiscal Q3 2023 ended 9/30/23. Get the latest Atreca Inc (BCEL) real-time quote, historical performance, charts, and other financial information to help you make more informed …